Cas no 138124-32-0 ((R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride)
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride Chemical and Physical Properties
Names and Identifiers
-
- (R,R)-(-)N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride
- (R,R)-Jacobsen's catalyst manganese(III) chloride complex
- (1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]manganese (III) chloride
- (R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) Chloride
- (1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]manganese (III) chloride, (R,R)-Jacobsen Cat.
- (1R,2R)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butyl-salicylidene)]manganese(III) chlorideSalen
- (R,R)-(-(+))-N,
- (R,R)-(-)-N N-Bis(3,5-DI-Tert-Butylsalicylidene)-1,2-Cyclohexanediamine-Manganese(Iii) Chloride
- (R,R)-(-)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINO-MANGANESE(III) CHLORIDE
- (R,R)-[N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine]manganese(III) Chloride
- (R,R)-(-)N,N‘-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride
- (R,R)-(-)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride
- i>)-(-)-<i>N<
- i>,<i>N<
- i>,<i>R<
- (R,R)-Jacobsen's Catalyst
- MFCD02101664
- AS-74616
- 45S483EOVD
- MANGANESE, CHLORO((REL-2,2'-((1R,2R)-1,2-CYCLOHEXANEDIYLBIS((NITRILO-.KAPPA.N)METHYLIDYNE))BIS(4,6-BIS(1,1-DIMETHYLETHYL)PHENOLATO-.KAPPA.O))(2-))-, (SP-5-13)-
- (N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine)manganese(III) chloride, (RS,RS)-
- WPP775Y8PO
- (R,R)-(N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine)manganese(III) chloride
- (N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine)manganese(III) chloride, (R,R)-rel-
- Jacobsen's catalyst (R,R)-form [MI]
- LJVAWOSDJSQANR-SEILFYAJSA-K
- AKOS037647740
- Jacobsen's catalyst [MI]
- MANGANESE, CHLORO((2,2'-((1R,2R)-1,2-CYCLOHEXANEDIYLBIS((NITRILO-.KAPPA.N)METHYLIDYNE))BIS(4,6-BIS(1,1-DIMETHYLETHYL)PHENOLATO-.KAPPA.O))(2-))-, (SP-5-13)-
- Jacobsen's catalyst(R,R)
- Manganese, chloro((rel-2,2'-((1R,2R)-1,2-cyclohexanediylbis((nitrilo-kappaN)methylidyne))bis(4,6-bis(1,1-dimethylethyl)phenolato-kappaO))(2-))-, (sp-5-13)-
- GEO-03071
- (1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butyl-salicylidene)]Mn(III) chloride
- UNII-45S483EOVD
- B5613
- (-)-Chloro((1R,2R)-4,4',6,6'-tetra-tert-butyl-2,2'-(cyclohexane-1,2-diylbis(nitrilomethylidyne))diphenolato(manganese(III)
- 138124-32-0
- 149656-63-3
- 2,4-ditert-butyl-6-[[(1R,2R)-2-[(3,5-ditert-butyl-2-oxidophenyl)methylideneamino]cyclohexyl]iminomethyl]phenolate;manganese(3+);chloride
- Manganese, chloro((2,2'-(1,2-cyclohexanediylbis(nitrilomethylidyne))bis(4,6-bis(1,1-dimethylethyl)phenolato))(2-)-N,N',O,O')-, (sp-5-13-(trans))-
- UNII-WPP775Y8PO
- Jacobsen's catalyst
- Manganese, chloro((2,2'-((1R,2R)-1,2-cyclohexanediylbis((nitrilo-kappaN)methylidyne))bis(4,6-bis(1,1-dimethylethyl)phenolato-kappaO))(2-))-, (sp-5-13)-
- DTXSID901028812
- (N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine)manganese(III) chloride, (R,R)-
- manganese(3+) 2,4-di-tert-butyl-6-({[(1R,2R)-2-[(E)-[(3,5-di-tert-butyl-2-oxidophenyl)methylidene]amino]cyclohexyl]imino}methyl)benzenolate chloride
- (R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride
-
- MDL: MFCD02101664
- Inchi: 1S/C36H54N2O2.ClH.Mn/c1-33(2,3)25-17-23(31(39)27(19-25)35(7,8)9)21-37-29-15-13-14-16-30(29)38-22-24-18-26(34(4,5)6)20-28(32(24)40)36(10,11)12;;/h17-22,29-30,39-40H,13-16H2,1-12H3;1H;/q;;+3/p-3/b37-21-,38-22+;;/t29-,30-;;/m1../s1
- InChI Key: LJVAWOSDJSQANR-UDMKAEFJSA-K
- SMILES: [Mn+3].[Cl-].[O-]C1=C(C=C(C=C1C(C)(C)C)C(C)(C)C)/C=N\[C@@H]1CCCC[C@H]1/N=C/C1C=C(C=C(C=1[O-])C(C)(C)C)C(C)(C)C
Computed Properties
- Exact Mass: 634.31000
- Monoisotopic Mass: 634.309775g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 42
- Rotatable Bond Count: 8
- Complexity: 537
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 6
- Topological Polar Surface Area: 70.8?2
Experimental Properties
- Color/Form: Brown powder
- Melting Point: 326°C(lit.)
- PSA: 43.18000
- LogP: 8.97270
- λmax: 509(CH2Cl2)(lit.)
- Merck: 5252
- Specific Rotation: D23 +580° (c = 0.01 in ethanol)
- Solubility: In most organic solvents, there are bettersolubility,Often inCH2Cl2Used in.
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride Security Information
-
Symbol:
- Prompt:warning
- Signal Word:Warning
- Hazard Statement: H315-H319
- Warning Statement: P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 36/37/38
- Safety Instruction: S26-S36/37/39
- FLUKA BRAND F CODES:9
-
Hazardous Material Identification:
- Risk Phrases:R20/21/22; R36/37/38
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride Customs Data
- HS CODE:29349990
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd. | 600056-10g |
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride |
138124-32-0 | 98% | 10g |
¥305.0 | 2024-07-19 | |
| SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd. | 600056-5g |
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride |
138124-32-0 | 98% | 5g |
¥160.0 | 2024-07-19 | |
| SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd. | 600056-1g |
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride |
138124-32-0 | 98% | 1g |
¥120.0 | 2024-07-19 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-TP851-5g |
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride |
138124-32-0 | 98% | 5g |
244.0CNY | 2021-07-16 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-TP851-1g |
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride |
138124-32-0 | 98% | 1g |
64.0CNY | 2021-07-16 | |
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | SY007841-5g |
(R,R)-(-)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) Chloride |
138124-32-0 | ≥95% | 5g |
¥134.0 | 2023-09-15 | |
| abcr | AB120963-1 g |
(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butyl-salicylidene)]Mn(III) chloride, 98%; . |
138124-32-0 | 98% | 1 g |
€51.90 | 2023-07-20 | |
| abcr | AB120963-5 g |
(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butyl-salicylidene)]Mn(III) chloride, 98%; . |
138124-32-0 | 98% | 5 g |
€167.00 | 2023-07-20 | |
| Chemenu | CM369078-25g |
(R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylid ene)-1,2-cyclohexanediamino-manganese(I)chloride |
138124-32-0 | 95%+ | 25g |
$87 | 2023-02-02 | |
| BAI LING WEI Technology Co., Ltd. | 404446-1G |
(R,R)-(?)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride |
138124-32-0 | - | 1G |
¥ 392 | 2022-04-25 |
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride Suppliers
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride Related Literature
-
Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
-
Chih-Yu Chang,Yu-Chia Chang,Wen-Kuan Huang,Wen-Chi Liao,Hung Wang,Chieh Yeh,Bo-Chou Tsai,Yu-Ching Huang J. Mater. Chem. A, 2016,4, 7903-7913
-
Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
-
Felix Witte,Philipp Rietsch,Nithiya Nirmalananthan-Budau,Florian Weigert,Jan P. G?tze,Ute Resch-Genger,Siegfried Eigler,Beate Paulus Phys. Chem. Chem. Phys., 2021,23, 17521-17529
-
Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
Additional information on (R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride
Introduction to (R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride and Its Significance in Modern Chemical Biology
Chemical compounds play a pivotal role in the advancement of pharmaceuticals and biotechnology. Among these, (R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride, with the CAS number 138124-32-0, has emerged as a compound of considerable interest due to its unique structural and functional properties. This compound, a manganese(III) complex, has garnered attention for its potential applications in catalysis, medicinal chemistry, and materials science. The intricate coordination sphere of this complex, featuring salicylidene ligands and a cyclohexane backbone, contributes to its distinctive reactivity and stability.
The synthesis and characterization of this compound have been subjects of extensive research. The use of Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine as a ligand system provides enhanced steric hindrance and electronic properties, which are crucial for tuning the redox behavior of the manganese center. This feature makes the compound an attractive candidate for applications in oxygen reduction reactions (ORRs) and other electrochemical processes. Recent studies have highlighted the importance of such manganese complexes in developing more efficient and durable catalysts for energy storage devices.
In the realm of medicinal chemistry, the development of metal-based therapeutics has seen significant advancements. Manganese complexes have been explored for their potential roles in treating neurological disorders, particularly those associated with oxidative stress. The chelation of manganese by the salicylidene ligands in (R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride not only stabilizes the metal center but also influences its biological activity. Preliminary studies suggest that this compound may exhibit neuroprotective properties by mitigating oxidative damage and modulating inflammatory responses.
The stereochemistry of the ligand system is another critical aspect that influences the biological activity of this compound. The (R,R) configuration provides a specific spatial arrangement that can interact with biological targets in a highly selective manner. This stereochemical control is essential for designing molecules with tailored pharmacological properties. Research has shown that such stereochemically defined complexes can exhibit improved binding affinities and reduced toxicity compared to their racemic counterparts.
The application of computational methods has further enhanced our understanding of the electronic structure and reactivity of this compound. Density functional theory (DFT) calculations have been employed to study the electronic properties of the manganese center and its interaction with the ligands. These studies have revealed insights into the mechanisms governing its catalytic activity and stability under various conditions. Such computational approaches are invaluable for guiding experimental efforts and optimizing the design of new metal complexes.
The role of this compound in materials science is also noteworthy. Manganese complexes have been explored as components in organic light-emitting diodes (OLEDs) and other optoelectronic materials. The unique electronic properties of these complexes contribute to their ability to facilitate charge transfer processes, which are essential for efficient device performance. Additionally, the stability provided by the tert-butyl groups in the ligand system enhances the durability of these materials under operational conditions.
Future directions in research on this compound include exploring its potential as a contrast agent in magnetic resonance imaging (MRI). The paramagnetic nature of manganese can be leveraged to enhance image contrast, providing a non-invasive method for visualizing biological processes. Furthermore, investigating its interactions with biological macromolecules may uncover new therapeutic applications or lead to insights into disease mechanisms.
In conclusion, (R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride represents a fascinating example of how structural design can lead to compounds with multifaceted applications. Its significance spans across catalysis, medicinal chemistry, and materials science, underscoring the importance of continued research in this area. As our understanding of its properties evolves, so too will its potential contributions to advancing technology and healthcare.
138124-32-0 ((R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminemanganese(III) Chloride) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)